LLY Looks 23.0% Undervalued on GF Value™ Amid Strategic Merida Biosciences Acquisition
· gurufocus.com
On August 31, 2026, Eli Lilly and Co (NYSE: LLY) announced its intent to acquire Merida Biosciences for up to $2.875 billion, a move that underscores Lilly's co
On August 31, 2026, Eli Lilly and Co (NYSE: LLY) announced its intent to acquire Merida Biosciences for up to $2.875 billion, a move that underscores Lilly’s ...